Our data are consistent with a recent study using a choline deficient mouse model of NAFLD/NASH which demonstrated a critical role for CCR2 in disease pathogenesis [15]. This evidence concerns the gene CCR2 and metabolic dysfunction-associated steatotic liver disease.